On November 21 Eastern Time, Eli Lilly and Co's market capitalization successfully surpassed $1 trillion, making it the world's first 'trillion-dollar' pharmaceutical company. The company’s stock price has risen by more than 35% this year, primarily driven by explosive growth in the weight-loss drug market. Wall Street analysts predict that the weight-loss drug market will reach $150 billion by 2030. Additionally, Eli Lilly and Co recently reached an agreement with the White House to lower the price of its weight-loss drugs, injecting a positive signal into its growth prospects. Do you have confidence in Eli Lilly and Co's future performance?